These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 3291231)
21. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation? Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519 [No Abstract] [Full Text] [Related]
22. Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine. Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin I; Gäbel H; Persson H; Groth CG Transplant Proc; 1987 Feb; 19(1 Pt 3):2074-9. PubMed ID: 3547910 [No Abstract] [Full Text] [Related]
23. Randomized prospective trial of elective cyclosporine withdrawal from triple therapy at 6 months after cadaveric renal transplantation. Hiesse C; Neyrat N; Deglise-Favre A; Lantz O; Bensadoun H; Benoit G; Charpentier B; Fries D Transplant Proc; 1991 Feb; 23(1 Pt 2):987-9. PubMed ID: 1989354 [No Abstract] [Full Text] [Related]
24. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression. Hoitsma AJ; Wetzels JF; Berden JH; Koene RA Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864 [No Abstract] [Full Text] [Related]
25. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation. Mourad G; Legendre C; Argiles A; Bonardet A; Mion C Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886 [No Abstract] [Full Text] [Related]
26. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients. Macris MP; Frazier OH; Van Buren CT; Duncan JM Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261 [No Abstract] [Full Text] [Related]
27. Long-term results of cyclosporine monotherapy in kidney transplantation. Griffin PJ; Salaman JR Transplant Proc; 1991 Feb; 23(1 Pt 2):992-3. PubMed ID: 1989356 [No Abstract] [Full Text] [Related]
28. Cyclosporine immunosuppression for more than three years in kidney transplants. Yagisawa T; Takahashi K; Toma H; Teraoka S; Fuchinoue S; Honda H; Agishi T; Ota K Transplant Proc; 1988 Jun; 20(3 Suppl 3):92-8. PubMed ID: 3291325 [No Abstract] [Full Text] [Related]
29. The case against conversion to azathioprine in cyclosporine-treated renal recipients. Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667 [No Abstract] [Full Text] [Related]
30. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients. Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530 [No Abstract] [Full Text] [Related]
31. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation. Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226 [No Abstract] [Full Text] [Related]
32. First month cyclosporine A sparing in renal transplantation. Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249 [No Abstract] [Full Text] [Related]
33. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation. Kootte AM; Lensen LM; van Bockel JH; Paul LC Transplant Proc; 1988 Jun; 20(3 Suppl 3):136-9. PubMed ID: 3291227 [No Abstract] [Full Text] [Related]
34. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study. Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359 [No Abstract] [Full Text] [Related]
35. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation. Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535 [No Abstract] [Full Text] [Related]
36. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
37. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy. Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239 [No Abstract] [Full Text] [Related]
39. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine. Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127 [No Abstract] [Full Text] [Related]
40. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation. Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]